Bios Health Group

Great article on building #passiveincome through #realestateinvesting .

At Bios Health, our strategic partners and team are evaluating assets for equity funding across these key areas: ●  Early-Stage (12-18 months from IND): o Oncology platform technologies with best-in-class potential and significant unmet need o Biologics across all therapeutic areas ●  Clinical-Stage (Phase 2 and above): o Metabolic disorders with best-in-class potential addressing high unmet need o Immunology treatments o Oncology advancements Do you have a groundbreaking biotech asset that aligns with our focus? Learn more and complete our investment assessment form to see if Bios Health can be your partner in success: https://lnkd.in/gA-Ma4sY #Biotech  #Innovation  #Healthcare  #LifeSciences  #Oncology  #MetabolicDisorders #ClinicalResearch  #Funding  #InvestingInBiotech  #VentureCapital  #Pharmaceuticals #DrugDevelopment  #BiotechFunding  #Immunology

At Bios Health, our strategic partners and team are evaluating assets for equity funding across these key areas: ●  Early-Stage (12-18 months from IND): o Oncology platform technologies with best-in-class potential and significant unmet need o Biologics across all therapeutic areas ●  Clinical-Stage (Phase 2 and above): o Metabolic disorders with best-in-class potential addressing high unmet need o Immunology treatments o Oncology advancements Do you have a groundbreaking biotech asset that aligns with our focus? Learn more and complete our investment assessment form to see if Bios Health can be your partner in success: https://lnkd.in/gA-Ma4sY #Biotech  #Innovation  #Healthcare  #LifeSciences  #Oncology  #MetabolicDisorders #ClinicalResearch  #Funding  #InvestingInBiotech  #VentureCapital  #Pharmaceuticals #DrugDevelopment  #BiotechFunding  #Immunology

We are thrilled to announce that Zizi Uzezi Imatorbhebhe, CEO of Bios Health Group, has been recognized as a 2024 PharmaVoice 100 honoree. With over 30 years of leadership in the Life Sciences and Biotechnology sectors, Zizi has been a driving force in helping biotech and life science companies navigate their most critical challenges. At Bios Health Group, she works closely with companies to support their capital raise efforts through both equity and debt financing. Leveraging her vast network of strategic investor partners, Zizi ensures that these companies secure the funding they need to advance groundbreaking therapies and technologies. Zizi also serves as a Subject Matter Expert for life science investors, providing portfolio management of their assets and strategic guidance to optimize their investments. Her ability to align the needs of companies with the right investors has made her a trusted leader in the industry. In addition to leading Bios Health Group, Zizi is the Managing Partner of Alliance Capital, a venture debt firm that provides capital without equity dilution. This innovative approach empowers companies to scale while maintaining ownership control. Zizi’s expertise spans investment strategy, clinical development, and commercial operations, and she is passionate about helping companies bring transformative solutions to market. Learn more: https://lnkd.in/epA2eyxS #PharmaVoice100 #Biotech #LifeSciences #VentureDebt #EquityFinancing #ClinicalDevelopment #CapitalRaise #BiotechInvestors #PortfolioManagement #HealthcareInnovation #Biotechnology #Leadership #WomenInSTEM #LifeScienceInvesting #Entrepreneurship #clinicalresearch #drugdevelopment #innovation #leaders #pharmaceutical #venturecapital #privateequity

Challenges Life Science Companies Face in Raising Capital 🔬 Life science companies encounter a unique set of challenges when raising capital: 1️⃣ Extended R&D and Clinical Timelines 2️⃣ Uncertain Regulatory and Commercialization Pathways 3️⃣ Market Volatility and Decreasing Valuations 4️⃣ Dilution of Ownership 5️⃣ De-Risking Expectations Don’t let capital interruptions slow your progress. Apply today to determine eligibility: https://lnkd.in/gvn-Jn_E #GrowthCapital #Biotech #venturedebt #LifeSciences #LifeScienceChallenges #CapitalRaising #Biotech #lifesciences #healthcare #medicaldevice #HealthcareIT #digitalhealth

The recent Fed rate cut makes now the ideal time for Biotech and Life Science companies to consider Venture Debt Capital. With our Venture Debt Capital Program, you can secure fast capital while maintaining full control of your business. Don’t let capital interruptions slow your progress. Apply today to determine eligibility: https://lnkd.in/ghTZYqHU #VentureDebt #GrowthCapital #Biotech #LifeSciences

The recent Fed rate cut makes now the ideal time for Biotech and Life Science companies to consider Venture Debt Capital. With our Venture Debt Capital Program, you can secure fast capital while maintaining full control of your business. Don’t let capital interruptions slow your progress. Apply today to determine eligibility: https://lnkd.in/ghTZYqHU  #VentureDebt #GrowthCapital #Biotech #LifeSciences

The recent Fed rate cut makes now the ideal time for Biotech and Life Science companies to consider Venture Debt Capital. With our Venture Debt Capital Program, you can secure fast capital while maintaining full control of your business. Don’t let capital interruptions slow your progress. Apply today to determine eligibility: https://lnkd.in/ghTZYqHU  #VentureDebt #GrowthCapital #Biotech #LifeSciences

Empower Your Innovation with Venture Debt Solutions 💡 Fuel your Life Science growth without giving up equity! Our Venture Debt Capital Program provides the funding you need to scale in a challenging capital landscape. 📈 Apply today at https://lnkd.in/gTEtjjn9 capital to complete a Capital Assessment Form. #Biotech #lifesciences #healthcare #medicaldevice #HealthcareIT #digitalhealth #diagnostics #labservices 

Need capital quickly without giving up equity? Bios Health Group offers Venture Capital Debt solutions tailored for Life Science and Healthcare companies. Raise funds fast, maintain control, and hit your next milestone with flexible, non-dilutive financing. Fuel your growth without dilution. Take the next step, Complete our Capital Assessment Form at https://lnkd.in/gvn-Jn_E to determine eligibility or schedule at meeting athttps://lnkd.in/gGJ3NgWe #capitaldebt #bioshealthgroup #capitaldebtsolution